These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17688403)

  • 1. Association of serotonin 2A receptor and lack of association of CYP1A2 gene polymorphism with tardive dyskinesia in a Turkish population.
    Boke O; Gunes S; Kara N; Aker S; Sahin AR; Basar Y; Bagci H
    DNA Cell Biol; 2007 Aug; 26(8):527-31. PubMed ID: 17688403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
    Basile VS; Ozdemir V; Masellis M; Meltzer HY; Lieberman JA; Potkin SG; Macciardi FM; Petronis A; Kennedy JL
    Mol Psychiatry; 2001 Mar; 6(2):230-4. PubMed ID: 11317228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
    Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK
    Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
    Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
    Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype.
    Lerer B; Segman RH; Tan EC; Basile VS; Cavallaro R; Aschauer HN; Strous R; Chong SA; Heresco-Levy U; Verga M; Scharfetter J; Meltzer HY; Kennedy JL; Macciardi F
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):411-25. PubMed ID: 15857569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.
    Basile VS; Ozdemir V; Masellis M; Walker ML; Meltzer HY; Lieberman JA; Potkin SG; Alva G; Kalow W; Macciardi FM; Kennedy JL
    Mol Psychiatry; 2000 Jul; 5(4):410-7. PubMed ID: 10889552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 1A2 co-determines neuroleptic load and may diminish tardive dyskinesia by increased inducibility.
    Ivanova SA; Toshchakova VA; Filipenko ML; Fedorenko OY; Boyarko EG; Boiko AS; Semke AV; Bokhan NA; Aftanas LI; Loonen AJ
    World J Biol Psychiatry; 2015 Apr; 16(3):200-5. PubMed ID: 25602162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between a functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and tardive dyskinesia in schizophrenia.
    Schulze TG; Schumacher J; Müller DJ; Krauss H; Alfter D; Maroldt A; Ahle G; Maroldt AO; Novo y Fernández A; Weber T; Held T; Propping P; Maier W; Nöthen MM; Rietschel M
    Am J Med Genet; 2001 Aug; 105(6):498-501. PubMed ID: 11496364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene.
    Chong SA; Tan EC; Tan CH; Mythily
    J Psychiatry Neurosci; 2003 May; 28(3):185-9. PubMed ID: 12790158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland].
    Gałecki P; Pietras T; Szemraj J
    Psychiatr Pol; 2006; 40(5):937-48. PubMed ID: 17217237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism.
    Tiwari AK; Deshpande SN; Lerer B; Nimgaonkar VL; Thelma BK
    Pharmacogenomics J; 2007 Oct; 7(5):305-11. PubMed ID: 16969362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
    Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML
    Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association analysis of functional polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene with tardive dyskinesia in Japanese patients with schizophrenia.
    Matsumoto C; Ohmori O; Shinkai T; Hori H; Nakamura J
    Psychiatr Genet; 2004 Dec; 14(4):209-13. PubMed ID: 15564895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs.
    Peñas-Lledó EM; Dorado P; Cáceres MC; de la Rubia A; Llerena A
    Clin Chem Lab Med; 2007; 45(7):835-8. PubMed ID: 17617023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia.
    Pae CU; Yu HS; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):495-500. PubMed ID: 15151706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia.
    Pae CU; Kim TS; Patkar AA; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH
    Psychiatry Res; 2007 Sep; 153(1):77-81. PubMed ID: 17582511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia.
    Hori H; Ohmori O; Shinkai T; Kojima H; Okano C; Suzuki T; Nakamura J
    Neuropsychopharmacology; 2000 Aug; 23(2):170-7. PubMed ID: 10882843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between dopamine D4 receptor gene -521 C/T polymorphism and tardive dyskinesia in schizophrenia.
    Lee HJ; Kang SG; Choi JE; Paik JW; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2007; 55(1):47-51. PubMed ID: 17556853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.